Filamin C is an essential protein for the integrity of the sarcomere and cytoskeleton of cardiomyocytes. Pathogenic variants in the FLNC gene are associated with a wide range of cardiomyopathies and may present distinct phenotypes depending on the type of genetic alteration. Truncated variants are frequently associated with dilated and arrhythmogenic cardiomyopathy, while missense variants are more related to hypertrophic and restrictive forms. These phenotypic differences reflect the molecular and structural impact of the FLNC variant on filamin C [...] Abstract Filamin C is an essential protein for the integrity of the sarcomere and cytoskeleton of cardiomyocytes. Pathogenic variants in the FLNC gene are associated with a wide range of cardiomyopathies and may present distinct phenotypes depending on the type of genetic alteration. Truncated variants are frequently associated with dilated and arrhythmogenic cardiomyopathy, while missense variants are more related to hypertrophic and restrictive forms. These phenotypic differences reflect the molecular and structural impact of the FLNC variant on filamin C
29 August 2023 in ABC Heart Failure & Cardiomyopathy
Arrhythmogenic cardiomyopathy with exclusive or predominant involvement of the left ventricle has been described recently. It has a heterogeneous genetic basis with different clinical phenotypes ranging from ventricular arrhythmias and sudden death (SD), symptoms suggestive of acute myocarditis with chest pain and troponin elevation, symptoms of heart failure, to asymptomatic patients. A high level of suspicion is needed for a correct diagnosis and implementation of a genotype-based therapy, to prevent its most feared complication, SD. This review aims to [...] Abstract Arrhythmogenic cardiomyopathy with exclusive or predominant involvement of the left ventricle has been described recently. It has a heterogeneous genetic basis with different clinical phenotypes ranging from ventricular arrhythmias and sudden death (SD), symptoms suggestive of acute myocarditis with chest pain and troponin elevation, symptoms of heart failure, to asymptomatic patients. A high level of suspicion is needed for a correct diagnosis and implementation of a genotype-based therapy, to prevent its most feared complication, SD. This review aims to
A Filamina C é uma proteína essencial para a integridade do sarcômero e do citoesqueleto dos cardiomiócitos. Variantes patogênicas no gene FLNC estão associadas a uma ampla gama de cardiomiopatias, podendo apresentar fenótipos distintos de acordo com o tipo de alteração genética. As variantes truncadas estão frequentemente associadas à cardiomiopatia dilatada e arritmogênica, enquanto as variantes missense são mais relacionadas às formas hipertrófica e restritiva. Essas diferenças fenotípicas refletem o impacto molecular e estrutural da variante FLNC na proteína filamina C, com implicações diretas no manejo clínico. O diagnóstico e a estratificação de risco são desafiadores e exigem uma abordagem multimodal que integre dados clínicos, genéticos e de imagem. A ressonância magnética cardíaca, em especial, é fundamental para a detecção de fibrose miocárdica e para a avaliação prognóstica. Evidências recentes indicam que variantes patogênicas no FLNC também podem estar associadas, raramente, a casos de miocardite aguda de apresentação grave, frequentemente acompanhada de arritmias ventriculares malignas e disfunção sistólica. O diagnóstico preciso, o acompanhamento contínuo e o aconselhamento familiar são fundamentais para definir a melhor abordagem terapêutica e prognóstica dos pacientes, em especial daqueles com alto risco de morte súbita cardíaca (MSC), permitindo desta forma, intervenções personalizadas e preventivas.